Vikas Kundra
7Patents
2h-index
4Co-inventors
40Inventor score
Filing activity: Feb 14, 2002 → Oct 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7176187B2 | Fusion proteins based upon somatostatin receptors | Chemistry; Metallurgy | 6 | Expired |
| US8278066B2 | Truncated somatostatin receptors | Chemistry; Metallurgy | 3 | Active |
| US8013114B2 | Fusion proteins based upon somatostatin receptors | Chemistry; Metallurgy | 2 | Active |
| US11541119B2 | Tumor treatment methods using cells that localize to the tumor | Chemistry; Metallurgy | 0 | Active |
| US9731023B2 | Somatostatin receptor-based cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US12097269B2 | Dual mode gadolinium nanoparticle contrast agents | Human Necessities | 0 | Active |
| US10493162B2 | Somatostatin receptor-based cancer therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.